Rare stomach cancer is a serious challenge for doctors. Most cases require a large open surgery to remove the tumor. This approach often leads to significant pain and a long recovery time. A report from China describes a different path for one patient. A 37-year-old woman faced this rare disease called gastric synovial sarcoma. Her medical team chose a minimally invasive technique called laparoscopic-endoscopic cooperative surgery. This method uses small incisions instead of one large cut. The goal was to remove the cancer completely while sparing the patient from the trauma of open surgery. The patient did not experience any local recurrence of the cancer. She also had no regional lymph node involvement or distant metastases. Her symptoms disappeared and she remained asymptomatic. Her performance status was good, meaning she felt well and could function normally. No adverse events were reported during her recovery. The follow-up period lasted nine postoperative months. This case suggests that this surgical approach is feasible and effective. It allows for complete removal of the tumor while avoiding the morbidity associated with open surgery. This report highlights a potential option for patients facing this difficult diagnosis.
Laparoscopic-endoscopic cooperative surgery achieves R0 resection in gastric synovial sarcoma with no recurrence at nine monthsA minimally invasive surgery helped a woman recover from rare stomach cancer
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This case report details the experience of a 37-year-old woman in China who underwent laparoscopic-endoscopic cooperative surgery for gastric synovial sarcoma. The intervention aimed to achieve complete resection while minimizing surgical trauma compared to open procedures. Follow-up lasted nine postoperative months during which the patient remained asymptomatic. No local recurrence, regional lymph node involvement, or distant metastases were observed. Gastrointestinal symptoms were absent, and the patient maintained good performance status throughout the observation period. Safety data, including adverse events and tolerability, were not reported in this single-case series. The study does not provide comparative efficacy data against standard open surgery. The authors suggest this approach is a feasible and effective minimally invasive strategy for achieving R0 resection. Clinicians should interpret these findings cautiously given the limited sample size and lack of a control group. Further research is needed to validate these outcomes in larger cohorts.